Overview

The Cancer of the Pancreas Screening-5 CAPS5)Study

Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.
Phase:
Phase 3
Details
Lead Sponsor:
Johns Hopkins University
Collaborators:
ChiRhoClin, Inc.
National Cancer Institute (NCI)
Treatments:
Pancreatin
Pancrelipase
Secretin